Epocrates remains the dominant medical application on physicians’ mobile devices in 2013 according to the recently released Manhattan Research Taking the Pulse® U.S. 2013 annual study of physicians’ technology adoption and behavior.

Taking the Pulse U.S. is Manhattan Research’s annual market research study and syndicated advisory service focused on how U.S. physicians use the Internet, digital media, mobile devices and other technologies for professional purposes and patient interaction. The study, which is done annually, was taken in Q1 among more than 3,000 physicians. Relevant findings from the Taking the Pulse U.S. study include:

Epocrates is the most popular medical application on both smartphone (70 percent) and tablet (50 percent) devices among U.S. physician app users

Thirty-four percent of physicians using Epocrates on a smartphone launch the app [Read more…]

Epocrates has announced a plan to offer free subscriptions for its premium mobile product to all U.S. medical students. The next generation of physicians is now heading back to school with an essential tool — Epocrates® Essentials drug, disease and diagnosis reference — at no cost.

“With more Americans potentially entering the healthcare system, future physicians will need access to top-notch training and the latest innovations. At Epocrates, we feel it is our responsibility to provide our nation’s medical students with a key resource that will help advance their education, and ultimately, their ability to deliver efficient, quality care,” said Andy Hurd, Epocrates’ president and chief executive officer.

Many top medical schools, such as Yale School of Medicine and Drexel University College [Read more…]

Epocrates, Inc. has announced the appointment of Andrew Hurd as president and chief executive officer, effective immediately. He will also serve on the company’s board of directors.

“Andy stood out as a natural leader with a proven track record and the expertise to generate growth and foster innovation. He has the distinct experience mix we were seeking and an appreciation of the complex healthcare industry,” said Patrick Jones, chairman of the Epocrates board of directors. “As a seasoned executive, we are confident he will continue to drive this dynamic company to the next level.”

Hurd brings more than 20 years of healthcare IT experience and leadership to Epocrates, including product and market innovation as well as strategic partnerships. He joins Epocrates from Carefx, acquired by Harris Corporation in 2011, where he served as chairman and CEO for more than six years. During his tenure, Carefx demonstrated strong growth in revenue, income and shareholder value. Previously, Hurd held senior management positions at WebMD Corp, CenterBeam, Inc. and QuadraMed Corporation. He also currently serves on the board of directors for ABILITY Network Inc.

“Epocrates is an incredibly powerful and established brand among healthcare professionals. It is an essential and trusted part of physicians’ daily practice and an ally in providing quality patient care,” said Hurd. “The company is positioned to play a significant role in the high-growth mobile healthcare ecosystem, and I’m excited to lead this company in its next chapter of growth and innovation.”

Peter Brandt will be stepping down as interim president and CEO effective March 27, 2012. He will take on the newly appointed role of vice chairman of the board of directors. As vice chairman, Brandt will work closely with Hurd to provide strategic counsel and ensure a smooth transition.

Epocrates, Inc. has announced Peter Brandt, a member of Epocrates’ board of directors, has been appointed as the company’s interim president and CEO. Brandt succeeds Rose Crane who stepped down from her position as president and CEO. The board has formed a search committee and initiated a search for a permanent replacement.

“Under Rose’s leadership, the company achieved an initial public offering, and she set the stage for future growth with the development and launch of innovative new

products,” said Patrick Jones, chairman of the Epocrates board of directors. “We thank Rose for her commitment and contributions and wish her well in her future endeavors.”

Peter Brandt, who joined the company’s board of directors in February 2011, has more than thirty years experience in the pharmaceutical industry. He most recently held the position of president and CEO of Noven Pharmaceuticals. He currently serves on the board of directors for Rexahn Pharmaceuticals, Auxilium Pharmaceuticals and the Population Council. [Read more…]

iMedicalApps is reporting that the developers of the popular Epocrates line of apps are offering Epocrates Essentials at no charge during the first two weeks of August. The product will be available to download FREE to all medical students who attend an accredited U.S. school.

From the site it appears to be a simple 3 step process to get your free copy. Step 1 – Either have or register for an Epocrates account. Step 2. Select your U.S. medical school. After completing those two steps the product is available for download as Step 3.